Chronic bloating, visceral pain, post-prandial fatigue: symptoms often put down to irritable bowel syndrome… but which can also be masking an excess of poorly metabolised histamine. Too often overlooked, digestive histamine intolerance is nonetheless an essential clinical lever in managing chronic digestive disorders.
Understanding histamine: a double-edged molecule
Essential for immune regulation and digestion, histamine becomes harmful when it builds up in excess. Produced by mast cells and certain gut bacteria, it acts in particular through H1 and H2 receptors, which modulate intestinal permeability, acid secretion and gut motility.
This imbalance is often seen in the context of dysbiosis, SIBO or impaired intestinal permeability. Undegraded histamine can then trigger a range of symptoms: intestinal spasms, bloating, nausea or post-meal fatigue.
Histamine and digestive disorders: thinking about the vicious circle
In many patients with IBS or dysbiosis, excess histamine sustains a self-perpetuating inflammatory cycle. Low-grade inflammation promotes increased permeability, which in turn reduces the activity of diamine oxidase (DAO), an enzyme crucial to the breakdown of histamine.
In addition, certain opportunistic bacteria, such as Helicobacter pylori, can increase endogenous histamine production, worsening digestive disorders.
Key points:
- Inflammation and histamine feed each other, driving the symptoms towards becoming chronic.
- Assessing intestinal permeability is a key element in the preventive approach.
Nutritional approaches: lightening the histamine load
A low-histamine diet can be a useful transitional strategy, particularly in acute phases. It can be combined with a low-FODMAP diet to optimise digestive tolerance. The gradual reintroduction phase is, however, crucial to avoid deficiencies.
Patient profileDietary approachClinical notesIBS + dysbiosisLow histamine + reduced FODMAPGradual reintroduction to be plannedPost-meal fatigueLow histamine + DAO supportAssess intestinal enzymatic activityVisceral pain+ Quercetin / CurcuminAntihistamine and anti-inflammatory effect
Micro-protocol: targeted histamine reduction in 3 phases
- Phase 1: temporary removal of histamine-rich foods
- Phase 2: enzymatic support (DAO) and microbiota regulation
- Phase 3: gradual reintroduction with symptom monitoring
Key points:
- Dietary restriction must remain temporary, followed by a well-matched reintroduction.
- Personalised support helps avoid prolonged, excessive restriction.
5 habits to build in from tomorrow
- Consider histamine in patients with multi-system digestive disorders
- Do not overlook the microbiota’s impact on histamine production
- Identify at-risk profiles: dysbiosis, permeability, SIBO
- Offer a clear reintroduction plan after any elimination diet
- Use DAO or quercetin as targeted support tools according to the profile
Essential points for your practice
An integrative approach to excess histamine can resolve certain therapeutic sticking points in chronic digestive disorders. It draws on simple but powerful tools (targeted nutrition, microbiota regulation, enzymatic support) to be built into a structured preventive strategy. Fully in keeping with the Simplycure ambition, these recommendations promote medicine that is more proactive, personalised and efficient.
Frequently asked questions (FAQ)
What is histamine intolerance?
It is an inability to properly metabolise histamine, leading to its accumulation and a range of digestive or systemic symptoms.
Which foods are rich in histamine?
Matured cheeses, cured meats, fermented foods, tinned fish, and certain fruits (banana, avocado…).
How can you assess a histamine-prone terrain?
Through the clinical history, identifying recurrent post-meal symptoms, and exploring dysbiosis or intestinal permeability if necessary.
Should histamine-rich foods be avoided for life?
No, temporary avoidance can be useful, but gradual reintroduction is essential to avoid nutritional imbalances.
When should DAO support be offered?
In the acute phase, in sensitive patients, alongside work on the microbiota and regulation of the inflammatory response.
